Millennium Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.39M | Buy |
318,449
+185,562
| +140% | +$3.72M | ﹤0.01% | 1920 |
|
|
2025
Q1 | $2.62M | Buy |
132,887
+82,083
| +162% | +$1.62M | ﹤0.01% | 2415 |
|
|
2024
Q4 | $1.14M | Buy |
50,804
+26,449
| +109% | +$595K | ﹤0.01% | 2816 |
|
|
2024
Q3 | $622K | Buy |
+24,355
| New | +$622K | ﹤0.01% | 3188 |
|
|
2023
Q2 | – | Sell |
-46,874
| Closed | -$1.03M | – | 4334 |
|
|
2023
Q1 | $1.03M | Buy |
+46,874
| New | +$1.03M | ﹤0.01% | 3022 |
|
|
2022
Q2 | – | Sell |
-2,577
| Closed | -$19K | – | 5192 |
|
|
2022
Q1 | $19K | Sell |
2,577
-15,386
| -86% | -$113K | ﹤0.01% | 5045 |
|
|
2021
Q4 | $162K | Sell |
17,963
-7,988
| -31% | -$72K | ﹤0.01% | 4753 |
|
|
2021
Q3 | $424K | Buy |
25,951
+17,235
| +198% | +$282K | ﹤0.01% | 4286 |
|
|
2021
Q2 | $275K | Buy |
8,716
+4,321
| +98% | +$136K | ﹤0.01% | 4554 |
|
|
2021
Q1 | $148K | Buy |
4,395
+4
| +0.1% | +$135 | ﹤0.01% | 4231 |
|
|
2020
Q4 | $387K | Buy |
+4,391
| New | +$387K | ﹤0.01% | 3400 |
|
|
2020
Q3 | – | Sell |
-2,768
| Closed | -$306K | – | 3672 |
|
|
2020
Q2 | $306K | Buy |
+2,768
| New | +$306K | ﹤0.01% | 2951 |
|